Beyond HD, GM1 promotes EV-mediated secretion of A53T α-synuclein and WT and mutant tau—pathogenic proteins implicated in familial PD, AD, and tauopathies, respectively—suggesting broader therapeutic potential. Here, MAPT is linked to Alzheimer disease.